Physician

Jiten Rana, M.D.

According to 2025 Medicare claims, Jiten Rana, M.D. (NPI: 1518068972) practices cardiology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (NPI: 1124122387; TIN: 232865181) and primary practice location at 08360-5843. Rana is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Rana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 888 traditional Medicare patients, billed 4,393 HCPCS/CPT codes, and received $232,164 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 7,184 prescription claims across 776 beneficiaries totaling $1,214,616 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 13 records totaling $445. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $367,035 to $232,164. In contrast, Part D prescription costs have moved sharply higher in recent years, from $195,240 to $1,214,616. For DME billing, this smaller-volume category rose steadily, from $8,409 to $29,963.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,340	5,610	$367,035
2016	1,644	6,840	$440,831
2017	1,615	6,293	$406,728
2018	1,492	5,552	$368,803
2019	1,208	4,999	$334,629
2020	900	3,738	$253,003
2021	906	4,788	$376,792
2022	938	4,124	$284,456
2023	1,027	4,629	$286,948
2024	888	4,393	$232,164

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	407	3,104	$195,240
2016	442	3,381	$226,760
2017	477	3,575	$234,761
2018	499	3,614	$241,262
2019	528	4,184	$326,155
2020	531	4,839	$419,365
2021	605	5,575	$709,123
2022	650	6,152	$994,723
2023	736	6,641	$1,205,789
2024	776	7,184	$1,214,616

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	64	$26,196
2017	N/R	30	$763
2018	N/R	15	$28,151
2019	N/R	11	$206
2020	N/R	N/R	N/R
2021	N/R	25	$51,594
2022	N/R	N/R	N/R
2023	N/R	52	$36,778
2024	N/R	11	$28,286

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	305	310	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	360	776	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	296	548	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	370	772	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	387	459	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	314	20,316	$381,522
Xarelto	Rivaroxaban	197	14,550	$259,460
Entresto	Sacubitril/Valsartan	101	7,190	$149,194
Repatha Sureclick	Evolocumab	86	5,276	$89,941
Jardiance	Empagliflozin	34	2,548	$48,495

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	11	$28,286

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$445	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jiten Rana, M.D.?

Tedicare shows public-source Medicare data for Jiten Rana, M.D. (NPI 1518068972), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jiten Rana, M.D. have ACO affiliation data?

Jiten Rana, M.D. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Jiten Rana, M.D.?

Jiten Rana, M.D. is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (billing NPI 1124122387) in the available physician profile data.

Does Jiten Rana, M.D. have Open Payments data?

Jiten Rana, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.